Fusion Antibodies are attending Bio-Europe Spring

Fusion Antibodies are pleased to be attending Bio-Europe Spring being held on 12-14th March in Amsterdam, The Netherlands.

With a focus on European innovation and global collaboration, Bio-Europe Spring is the premier springtime partnering conference bringing together a “who’s who” from biotech, pharma and finance in the most innovative biopharma clusters in Europe.

Last year, in 2017, Bio-Europe Spring catered to over 2500 delegates from across 54 countries participating in over 15,000 one-to-one meetings.

Fusion Antibodies CEO, Paul Kerr and Business Development Executive, Hayley Close will be attending this event. Get in touch today to organise a meeting.

To find out more information about Bio-Europe Spring or to book your place, please visit their website.  

We look forward to seeing you there!